Search

everythinglearnresearchcommunity

for

Search:↓

Early-stage male pattern baldness shows two types of hair loss: one on the top of the head linked to hormonal changes, and another at the back of the head. The top hair loss responds well to specific treatment, while the back hair loss does not.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

Androgenic alopecia in men is mainly linked to family history, hormonal imbalances, and metabolic issues, but can also be influenced by lifestyle habits, environmental factors, and deficiencies in certain vitamins and microelements like copper.

PRP is an effective and safe treatment for female hair loss.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Food intake, not genetics, affects how the body processes tadalafil and finasteride.

Tamsulosin increases the risk of floppy iris during eye surgery.

Injecting a person's own fat stem cells into their skin can make it look younger and improve double eyelids for over a year.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

A new gene, JMJD1C, may affect testosterone levels in men.

C-scores can help predict gain-of-function and loss-of-function mutations.

Using old drugs for new uses can help treat rare immune deficiencies.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Platelet-based therapies using a patient's own blood show promise for skin and hair regeneration but require more research for confirmation.

BTA safely and effectively treats hair loss, and works better with FNS.

Hair characteristics might be early signs of Type 2 Diabetes and could help with early prevention.

Certain MC4R gene variants are linked to higher BMI in obese women with PCOS but do not cause PCOS.

Men with early balding may have hormonal imbalances similar to women with PCOS and could benefit from similar treatments.

Post-finasteride syndrome's existence is uncertain; more research needed.

Platelet-rich plasma (PRP) speeds up skin wound healing and has potential in medical and cosmetic uses.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Essential oils like lavender, chamomile, and bergamot help manage stress and improve well-being.

Plasma gel and PRP treatments improve skin and hair with minimal side effects.

Dianabol boosts muscle growth but has serious health risks and legal issues.